SCHEMBL10259398

SCHEMBL10259398

Cc1ccc2c(cnc3cc(C)ccc32)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.47
CHEK1 O14757 1/20 0.46
PARP1 P09874 1/20 0.46
PIM1 P11309 1/20 0.46
RPS6KA3 P51812 1/20 0.46
CYP1A2 P05177 6/20 0.44
HTR1A P08908 2/20 0.43
ADRA1D P25100 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA1B P35368 2/20 0.43
ALDH1A1 P00352 3/20 0.42
CYP2A6 P11509 2/20 0.42
KDM4E B2RXH2 3/20 0.42
GPR3 P46089 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
PSMB5 P28074 1/20 0.40
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13915654 0.86 KDM4E (0.62) NQO2CHEK1PARP1PIM1RPS6KA3
SCHEMBL18266925 0.86 GPR3 (0.62) NQO2CYP1A2ALDH1A1CYP2A6KDM4E
SCHEMBL28988476 0.86 ALDH1A1 (0.46) NQO2PARP1CYP1A2HTR1AADRA1D
SCHEMBL30406008 0.86 ALDH1A1 (0.46) NQO2PARP1CYP1A2HTR1AADRA1D
SCHEMBL3503084 0.77 PDE10A (0.45) RPS6KA3L3MBTL1MAPT
SCHEMBL862474 0.75 CCR1 (0.54) NQO2CHEK1PARP1PIM1RPS6KA3
SCHEMBL12313649 0.75 CYP1A2 (0.42) NQO2CHEK1PARP1PIM1RPS6KA3
SCHEMBL2230568 0.75 ALDH1A1 (0.56) NQO2CHEK1PARP1PIM1RPS6KA3
SCHEMBL19007835 0.74 ALDH1A1 (0.56) CHEK1PARP1PIM1RPS6KA3CYP1A2
SCHEMBL19007832 0.74 KDM4E (0.53) NQO2CYP1A2ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2518111-B1 COMPOSITION AND LUMINESCENT ELEMENT OBTAINED USING SAME SUMITOMO CHEMICAL CO (JP) 2019-03-13 EP disclosed
US-9780308-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-03 US disclosed
US-9780308-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-03 US disclosed
EP-2308910-B1 POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL CO (JP) 2017-03-01 EP disclosed
US-8999523-B2 Compound containing 1,3-diene structure and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-07 US disclosed
US-8999523-B2 Compound containing 1,3-diene structure and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-07 US disclosed
US-8993124-B2 Polymer compound comprising aryl repeating units with crosslinking pendent groups and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-03-31 US disclosed
US-8993124-B2 Polymer compound comprising aryl repeating units with crosslinking pendent groups and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-03-31 US disclosed
US-8895768-B2 Cyclopara (hetero) arylene compound and method for producing same KYOTO UNIVERSITY (JP) 2014-11-25 US disclosed
US-8895768-B2 Cyclopara (hetero) arylene compound and method for producing same KYOTO UNIVERSITY (JP) 2014-11-25 US disclosed
US-20080220286-A1 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films TSINGHUA UNIVERSITY (CN) 2008-09-11 US disclosed
US-20080220286-A1 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films TSINGHUA UNIVERSITY (CN) 2008-09-11 US disclosed
US-20080107914-A1 Composition for Conductive Materials Comprising Tetra Acrylate Functionalised Arylamines, Conductive Material and Layer, Electronic Device and Equipment SEIKO EPSON CORPORATION (JP) 2008-05-08 US disclosed
US-20080107914-A1 Composition for Conductive Materials Comprising Tetra Acrylate Functionalised Arylamines, Conductive Material and Layer, Electronic Device and Equipment SEIKO EPSON CORPORATION (JP) 2008-05-08 US disclosed
US-20070286997-A1 Material Composition for Conductive Layers in Electronic Devices SEIKO EPSON CORPORATION (JP) 2007-12-13 US disclosed
US-20070286997-A1 Material Composition for Conductive Layers in Electronic Devices SEIKO EPSON CORPORATION (JP) 2007-12-13 US disclosed
WO-2007043675-A9 COMPOSITION FOR CONDUCTIVE MATERIALS, CONDUCTIVE MATERIAL, CONDUCTIVE LAYER, ELECTRONIC DEVICE, AND ELECTRONIC EQUIPMENT SEIKO EPSON CORP (JP) 2007-06-07 WO disclosed
WO-2007043675-A1 COMPOSITION FOR CONDUCTIVE MATERIALS, CONDUCTIVE MATERIAL, CONDUCTIVE LAYER, ELECTRONIC DEVICE, AND ELECTRONIC EQUIPMENT SEIKO EPSON CORPORATION (JP) 2007-04-19 WO disclosed
WO-2007043603-A1 COMPOSITION FOR CONDUCTIVE MATERIALS SEIKO EPSON CORPORATION (JP) 2007-04-19 WO disclosed
WO-2007010880-A1 LIGHT EMITTING DEVICE AND ELECTRONIC EQUIPMENT PROVIDED WITH THE LIGHT EMITTING DEVICE SEIKO EPSON CORPORATION (JP) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070286997-A1 Material Composition for Conductive Layers in Electronic Devices C1S, KCNH3, SLC9A2 NQO2 3441/4885CHEK1 3636/4885PARP1 2875/4885
US-20080220286-A1 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films EED, DDT, RABL6 NQO2 1077/4885CHEK1 4590/4885PARP1 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.